Amoxil: Effective Bacterial Infection Treatment with Broad-Spectrum Coverage
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.01 | $40.16 (0%) | 🛒 Add to cart |
| 30 | $1.51 | $60.24 $45.18 (25%) | 🛒 Add to cart |
| 60 | $0.92 | $120.48 $55.22 (54%) | 🛒 Add to cart |
| 90 | $0.67 | $180.73 $60.24 (67%) | 🛒 Add to cart |
| 120 | $0.59 | $240.97 $70.28 (71%) | 🛒 Add to cart |
| 180 | $0.56 | $361.45 $100.40 (72%) | 🛒 Add to cart |
| 270 | $0.45 | $542.18 $120.48 (78%) | 🛒 Add to cart |
| 360 | $0.39
Best per pill | $722.90 $140.56 (81%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.02 | $40.16 (0%) | 🛒 Add to cart |
| 20 | $2.26 | $80.32 $45.18 (44%) | 🛒 Add to cart |
| 30 | $1.67 | $120.48 $50.20 (58%) | 🛒 Add to cart |
| 60 | $1.00 | $240.97 $60.24 (75%) | 🛒 Add to cart |
| 90 | $0.73 | $361.45 $65.26 (82%) | 🛒 Add to cart |
| 120 | $0.67 | $481.94 $80.32 (83%) | 🛒 Add to cart |
| 180 | $0.61 | $722.90 $110.44 (85%) | 🛒 Add to cart |
| 240 | $0.50 | $963.87 $119.48 (88%) | 🛒 Add to cart |
| 360 | $0.47
Best per pill | $1445.81 $170.69 (88%) | 🛒 Add to cart |
Synonyms
| |||
Amoxil (amoxicillin) is a widely prescribed penicillin-class antibiotic renowned for its clinical efficacy against numerous bacterial pathogens. As a semi-synthetic derivative, it combines enhanced stability with superior absorption characteristics, making it a first-line therapeutic option for both community and hospital settings. Its bactericidal action disrupts cell wall synthesis, providing rapid resolution of infections when administered appropriately under medical supervision. Healthcare professionals consistently rely on Amoxil for its predictable pharmacokinetics and well-established safety profile across diverse patient populations.
Features
- Contains amoxicillin trihydrate equivalent to 250mg, 500mg, or 875mg amoxicillin per tablet
- Available as capsules, tablets, chewable tablets, and oral suspension formulations
- Exhibits acid-stability for reliable oral absorption unaffected by gastric pH
- Demonstrates time-dependent bactericidal activity against susceptible organisms
- Manufactured under cGMP standards with consistent bioavailability between batches
- Includes potassium clavulanate in augmented formulations to overcome beta-lactamase resistance
Benefits
- Rapid onset of action with peak serum concentrations achieved within 1-2 hours post-administration
- Comprehensive coverage of Gram-positive and select Gram-negative pathogens
- Flexible dosing regimens adaptable to various infection severities and patient demographics
- High tissue penetration ensuring therapeutic concentrations at infection sites
- Established safety profile permitting use in pediatric, geriatric, and pregnant populations (Category B)
- Minimal interference with routine laboratory testing parameters
Common use
Amoxil is indicated for the treatment of infections caused by susceptible strains of microorganisms including Streptococcus species (pharyngitis, tonsillitis, otitis media), Staphylococcus species (skin and soft tissue infections), Escherichia coli (urinary tract infections), Haemophilus influenzae (bronchitis, pneumonia), and Helicobacter pylori (peptic ulcer disease, typically in combination therapy). It is also employed for dental abscesses, Lyme disease, and prophylactically against bacterial endocarditis in high-risk patients undergoing dental procedures.
Dosage and direction
Dosage must be individualized based on infection severity, pathogen susceptibility, and patient factors. For mild to moderate infections: Adults: 250-500 mg every 8 hours or 500-875 mg every 12 hours. Children: 20-50 mg/kg/day divided every 8-12 hours (maximum 2-3 g/day). For severe infections or those caused by less susceptible organisms: Adults: 500-875 mg every 8 hours or 875 mg every 12 hours. Children: 40-90 mg/kg/day divided every 8-12 hours (maximum 3-4 g/day). Administer orally without regard to meals, though gastrointestinal upset may be minimized with food. Complete the entire prescribed course even if symptoms resolve earlier.
Precautions
Monitor renal function periodically during extended therapy; dosage adjustment required for creatinine clearance <30 mL/min. Use with caution in patients with mononucleosis due to increased risk of maculopapular rash. May result in fungal or bacterial superinfection; discontinue if superinfection occurs. Prolonged use may promote nonsusceptible organism overgrowth. Perform culture and susceptibility testing before initiating therapy when practicable. Alert patients that oral suspensions require refrigeration and discard after 14 days.
Contraindications
Hypersensitivity to amoxicillin, other penicillins, or any component of the formulation. History of amoxicillin-associated cholestatic jaundice/hepatic dysfunction. Previous hypersensitivity reaction to beta-lactam antibiotics (cross-sensitivity between penicillins and cephalosporins may occur). Concomitant administration with disulfiram (for certain formulations containing alcohol). Infectious mononucleosis (due to high incidence of erythematous rash).
Possible side effect
Common reactions (>1%): diarrhea, nausea, vomiting, skin rash, urticaria, vaginal candidiasis. Less frequent: abdominal discomfort, headache, reversible leukopenia, thrombocytopenia, eosinophilia. Rare but serious: anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis, hepatitis, cholestatic jaundice, pseudomembranous colitis, interstitial nephritis, hemolytic anemia, serum sickness-like reactions. Immediately discontinue and institute appropriate therapy for severe reactions.
Drug interaction
Probenecid decreases renal tubular secretion of amoxicillin, increasing and prolonging serum concentrations. Allopurinol may increase incidence of skin rash. May reduce efficacy of oral contraceptives; recommend alternative contraception during therapy. Concurrent use with methotrexate may increase methotrexate toxicity. May potentiate warfarin effect through reduction of vitamin K-producing gut flora. Bacteriostatic antibiotics (e.g., tetracyclines, chloramphenicol) may interfere with bactericidal action.
Missed dose
Administer the missed dose as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose to make up for the missed administration. Maintain regular dosing intervals to ensure consistent therapeutic serum levels. If multiple doses are missed, contact healthcare provider for guidance on regimen adjustment.
Overdose
Manifestations may include gastrointestinal distress (nausea, vomiting, diarrhea), electrolyte imbalances, and crystalline. Management consists of supportive care with attention to electrolyte and fluid balance. Amoxicillin is removed by hemodialysis; institute dialysis if significant overdose occurs, particularly in renal impairment. Monitor renal function for several days post-overdose.
Storage
Store tablets and capsules at controlled room temperature (20-25°C/68-77°F) in tightly closed containers. Protect from moisture and light. Reconstituted oral suspension remains stable for 14 days under refrigeration (2-8°C/36-46°F); discard unused portion after this period. Do not freeze liquid formulations. Keep all medications out of reach of children and pets.
Disclaimer
This information does not constitute medical advice. Amoxil is a prescription medication requiring professional medical supervision. Healthcare providers must consider individual patient factors before prescribing. Always follow the specific guidance provided by the treating physician and the official prescribing information. Report any adverse reactions to the appropriate regulatory authority.
Reviews
Clinical studies demonstrate amoxicillin achieves clinical cure rates of 85-95% for streptococcal pharyngitis and 80-90% for acute otitis media when caused by susceptible organisms. Meta-analyses confirm its position as first-line therapy for community-acquired respiratory infections. Pediatric studies show equivalent efficacy to alternative antibiotics with favorable tolerability profiles. The addition of clavulanate extends coverage to beta-lactamase-producing strains, maintaining clinical relevance despite evolving resistance patterns.